Allows the Alabama Medicaid Agency to apply the reimbursement basis for inpatient and outpatient hospital services for State fiscal year 2022 (Medicare and cost, respectively) used in fiscal year 2021 including an adjustment to utilization trends impacted by COVID-19.

This amendment removes coverage of the Nurse Advice Line from the state plan as the result of increased access to primary care advice through telehealth.

The SPA attests to the state’s coverage of COVID-19 treatment, as required by section 1905(a)(4)(F) of the Social Security Act. CMS supports this change, as it is required by statute.

This SPA attests to the state’s coverage of COVID-19 testing, as required by section 1905(a)(F)(4) of the Social Security Act. CMS supports this change, as it is required by statute.

CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency.  The purpose of this amendment is to temporarily eliminate the "Deprivation" requirement relating to dependent children living with individuals who seek Medicaid on the basis of being parents and other caretaker relatives.

CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency.  The purpose of this amendment is to modify the Personal Care and Personal Care assistance from the previously approved flexibilities in MO 20-0012. The modifications are to face to face visits, telephone signatures and training requirements.

CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency.  The purpose of this amendment is end Nursing Facility COVID Relief Rate (NF CRR) Payments to Medicaid enrolled nursing facilities.

CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency.  The purpose of this amendment is to increase the reimbursement rate for the Newborn Metabolic Screenings effective July 1, 2020.

This amendment updates the State's Supplemental Rebate Agreement’s (SRA) applicable date of the new Sovereign States Drug Consortium (SSDC) rebate agreement.

Adds coverage of COVID-19 testing, vaccine, administration, and treatments